Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Finasteride not cost effective for prostate cancer prophylaxis

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Finasteride not cost effective for prostate cancer prophylaxis. Pharmacoecon. Outcomes News 490, 11 (2005). https://doi.org/10.2165/00151234-200504900-00028

    Download citation

    Keywords

    • Public Health
    • Prostate Cancer
    • Health Outcome
    • Markov Model
    • Health Economic